Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.
about
In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models.Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance studyMolecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002Erythromycin-resistant group a streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types.Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae.Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites.Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central GreeceEmergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A).Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E)Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin.Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.Macrolide resistance in Streptococcus pneumoniae in Hong Kong.Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae.Clindamycin-resistant Streptococcus pneumoniae.
P2860
Q33182007-2EF08FFE-2D08-4019-844B-C2A6A6D5CFF5Q33753151-88141566-F724-4DEC-B780-26DBD65ADD38Q33856609-E2E15555-8778-4A32-84A9-C77C69706E53Q33858900-37DBAB6B-53FC-44BA-808D-2FB0C31D0C33Q33971827-AB06170D-B157-4D9E-8E00-304885EA2981Q33979988-5DF8B480-D562-45A3-B1FA-9C71D77C28A0Q33980655-B879B8DC-E009-4DA3-B2F4-82C11DD49B45Q33981528-751564FE-D58F-4784-A404-8BDD74A275D2Q33982950-3493239A-1D24-4B05-AD38-3210E674AA6EQ34076998-1D45C47D-9123-4818-92F4-1B9D0F10E3F7Q34109184-188E1EA9-8104-4537-966E-1E65939671B6Q34195993-98FC7363-FB6B-4B12-87F7-8BAA0BAE9181Q34443354-890226BA-C00D-4707-B890-BAF56872DC79Q34487628-8B194EFE-E270-46B0-A945-585269ACF6BFQ35166053-8DD4A3FF-F664-4691-9DD6-120D941F244FQ35590537-11140469-815B-46C5-9A42-363915C651E8Q36081307-2CF3E706-A961-4C4F-B0C0-15DF16380C20Q36170473-49729AE5-9ED5-454D-92D2-0ACD362F8DABQ36667222-BD3E290E-06B6-473D-A6F2-E7780B479BAAQ38523119-C82F39AA-7531-4EF0-9355-3F23F880859EQ39476086-89594A66-B692-46CE-A1C1-ED286F95601CQ39477280-DAA9CD8D-F991-4651-B85E-A4EB8AFC8B91Q39626747-82D2DC6E-5E16-493A-B84F-E3F89FA1BE01Q42546908-5624D247-95A2-4967-BD03-8B7350A2FA0B
P2860
Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Patterns of macrolide resistan ...... acrolide susceptibility rates.
@ast
Patterns of macrolide resistan ...... acrolide susceptibility rates.
@en
type
label
Patterns of macrolide resistan ...... acrolide susceptibility rates.
@ast
Patterns of macrolide resistan ...... acrolide susceptibility rates.
@en
prefLabel
Patterns of macrolide resistan ...... acrolide susceptibility rates.
@ast
Patterns of macrolide resistan ...... acrolide susceptibility rates.
@en
P2093
P2860
P356
P1476
Patterns of macrolide resistan ...... macrolide susceptibility rates
@en
P2093
Lattanzi M
Montagnani F
Rossolini GM
P2860
P304
P356
10.1128/AAC.43.10.2510
P407
P577
1999-10-01T00:00:00Z